Cytokinetics incorporated

Major-Pharmaceuticals

CYTK


280 East Grand Avenue
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 49.37
    $ +0.42 0.87 %
    Jan 3, 2025
  • 52-Week High/Low
  • $108.06 - $26.88
  • YTD
  • 5%

  • Trading Volume
  • 20,166
  • Market Cap Full
  • $ 4.8B
  • Shares Outstanding
  • 98.1M
    Nov 1, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -32.6% 5.8% -11.7% 28% -5% 11.9% -19.2% -23.2% -15.9% 5%
Q2 34.6% -5.8% 20.3% 40.3% 4% -14.9% 6.7% -7.3% -26% -
Q3 -3.3% 19.8% 13.2% -0.7% 8% 82% 23.3% -9.7% -2.9% -
Q4 32.4% -45.3% -29.9% -6.9% -4% 26.6% -5.4% 199.5% -15.7% -
J F M A M J J A S O N D
2025 5% - - - - - - - - - - -
2024 -6.4% -7.5% -2.8% -3.9% -28.2% 11.7% 9.2% -2.9% - - - -9.4%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    31%16%-33%-22%69%95%119%1%82%-44%5%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.31 0.62 -0.56 -0.54 - - - -1.38
Q2 0.29 0.60 -0.51 -0.56 - - - -1.34
Q3 0.74 0.60 -0.4 -0.5 - - - -1.35
Q4 0.16 0.75 -0.48 -2.11 -1.97 -2.8 -1.53 -
A 1.5 2.6 -2 -3.7 -2 -2.8 -4.3 -4.07

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 54.9 59.5 71.1 84.9 95.2
Jun 54.2 57.7 59.5 71.7 85.7 95.6
Sep 54.6 58.7 70.5 83.5 94.1 96
Dec 54.7 59.1 70.8 83.9 94.6 98.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.7 0.3 1.1 0.6 10.7
Total Asset Turnover 0.1 0.1 0.1 0.1 0.2
Leverage
Debt Ratio 0.1 0.1 0.1 0.2 0.2
Debt – Equity Ratio -0.6 0.2 0.4 -4.1 1.5
Interest Coverage -5 -6.4 -2.9 -4.3 -5.2
Equity multiplier -1.3 1 0.4 -4.4 0.1